News and Announcements
TUDI launching property prediction algorithm following refinement
- Published September 05, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
A message from TUDI.
You haven’t heard from us in a while because we’ve been busy.
Busy refining the TUDI property prediction algorithm and developing the online platform that will give you first access to exclusive property investment insights.
And we’re excited to announce the platform is launching next week!
Our property market prediction platform will revolutionise property investment by providing invaluable decision-making insights that show you exactly where & when to invest for success.
The platform combines a wealth of premium data from multiple sources – data that has previously only been available to professional investors.
And powered by AI, big data and years of property analysis, our algorithm not only highlights Hot-Spot suburbs that will outperform the market but also indicates the best time to sell. This intel makes the market more accessible and provides high-return, lower-risk investment opportunities for all.
Think of TUDI as your personal property investment advisor.
Our Virtual Portfolio is killing the market
We built a Virtual Portfolio to test the performance of the prediction algorithm.
And despite house prices falling since September 2017, the overall performance of the Virtual Portfolio has seen an overall return of a whopping 33%! We’ve seen suburb returns as high as Branxton in NSW at 51%, or Nickol in WA which has grown 40% in just 21 months.
When the platform goes live next week, we will be sure to announce it.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
